We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Swiss drugmaker Roche and U.S.-based Trimeris have mutually agreed to amend their research agreement to extend the research term by additional two years from Jan. 1, 2007, through Dec. 31, 2008.
Japanese drugmaker Takeda has announced results of new studies that show Actos (pioglitazone HCl), an oral antidiabetic medication, significantly reduced the risk of recurrent stroke in high-risk patients with Type 2 diabetes.
Xanthus Pharmaceuticals, Inc., a privately held oncology drug development company, announced that the company has acquired from Schering AG, Berlin, the exclusive worldwide rights to develop
and commercialize a group of targeted cancer compounds.
SkyePharma PLC announces that it has entered into an agreement with Mundipharma International Corporation Limited ("Mundipharma") for the development, marketing and distribution in Europe and certain other international markets of Flutiform, its novel combination product for asthma and chronic obstructive pulmonary disease ("COPD").
Cancer Research Technology (CRT), the oncology-focused development and commercialisation company wholly owned by Cancer Research UK, announce that they have entered into an agreement with AstraZeneca focused on colorectal cancer.
At the request of the U.S. Food and Drug Administration (FDA), on September 5, 2006, U.S. Marshals seized quantities of Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules, and Advanced Arthritis Support capsules distributed by Advantage Nutraceuticals L.L.C. of Fort Walton Beach, Florida, valued at approximately $55,000.00.
Sanofi-aventis has withdraw the European application for marketing authorisation of dronedarone, 400 mg film-coated tablets intended for use in the treatment of atrial fibrillation.
Merck & Co.'s board of directors said Wednesday that a 20-month investigation funded by the company found that senior management acted responsibly in its development and marketing of its now-withdrawn pain reliever Vioxx.
The United Nations Children's Fund (UNICEF) and the government of Liberia have launched a campaign to administer vitamin A supplementation and deworming tablets to children under the age of 5.